AID Antibodies

Santa Cruz Biotechnology features a diverse variety of AID Antibodies for research focused on understanding Activation-Induced Cytidine Deaminase (AID) in various biological processes. Monoclonal AID Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Activation-Induced Cytidine Deaminase is crucial for somatic hypermutation and class switch recombination in B cells, playing a significant role in the adaptive immune response. AID facilitates the diversification of antibody genes, contributing to the generation of high-affinity antibodies essential for effective immune defense. Research involving AID provides critical insights into immunological disorders and supports the development of targeted therapies. Scientists investigating immune system regulation can rely on robust experimental data generated through the use of AID monoclonal antibodies. Comprehensive characterization of AID expression and activity advances the understanding of immune responses and disease mechanisms. Santa Cruz Biotechnology monoclonal AID antibodies enable researchers worldwide to make meaningful contributions to immunology research and therapeutic development.